Clinical Trial Update: ATHENAS - Retrospective Study of Compliance in Chronic Hepatitis C With Pegylated Interferon Alfa-2b/Ribavirin in Brazil (P05632)

View source ↗

Summary

Retrospective study examining patient compliance with pegylated interferon alfa-2b plus ribavirin for chronic hepatitis C in Brazil; the ATHENAS study was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated Interferon Alfa-2b (pegylated interferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic | Status: TERMINATED | Results posted: 2011-11-28